Vinzolidine
Alternative Names: LY 104208Latest Information Update: 26 Jul 1994
At a glance
- Originator Eli Lilly and Company
- Class Antineoplastics; Vinca alkaloids
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer